Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Annals of Surgical Oncology|June 28, 2018
Correction to: 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Annals of Surgical Oncology|June 1, 2018
1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility StudyMarc D Moncrieff, David Gyorki, Robyn Saw, et al.
Annals of Surgical Oncology|September 21, 2010
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes fails to predict breast cancer recurrence: a final analysis of a prospective multi-institutional cohort studyCarla Suzanne Fisher, David J Cole, Michael Mitas, et al.
Annals of Surgical Oncology|March 27, 2019
Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter AnalysisJohn T Miura, Hidde M Kroon, Georgia M Beasley, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 3, 2020
Factors predicting toxicity and response following isolated limb infusion for melanoma: An international multi-centre studyTimothy J Kenyon-Smith, Hidde M Kroon, John T Miura, et al.
Annals of Surgical Oncology|March 11, 2020
International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian PatientsJüri Teras, Hidde M Kroon, John T Miura, et al.
Annals of Surgical Oncology|September 12, 2020
Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and AustraliaMichael J Carr, James Sun, Hidde M Kroon, et al.
Annals of Surgery|May 29, 2004
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort studyWilliam E Gillanders, Kaidi Mikhitarian, Renee Hebert, et al.
Pathology|December 23, 2021
BRAF mutation testing for patients diagnosed with stage III or stage IV melanoma: practical guidance for the Australian settingRichard A Scolyer, Victoria Atkinson, David E Gyorki, et al.
Pageof 8